FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ INDEXPEPPUDEX
PINEALON trading card

NO. 046 · BASIC · Lv. 62 · HP 100

PINEALON

Brain Bioregulator Tripeptide · Khavinson

REVIEWED BY · PEPPU STUDIO RESEARCH DESK·LAST UPDATED · 2026-05-25
COGNITIONLONGEVITY

ALIASES

Pinealon, Glu-Asp-Arg, EDR tripeptide, Khavinson brain bioregulator

CLASS

Synthetic tripeptide · Khavinson short-peptide bioregulator (brain)

FORMULA

C15H26N6O8

SEQUENCE

Glu-Asp-Arg

HALF-LIFE

Short (minutes) plasma · longer CNS retention reported

ROUTES

Intranasal (Russian clinical literature) · Subcutaneous (research) · Oral (research)

MECHANISM OF ACTION

Synthetic tripeptide Glu-Asp-Arg developed at the St. Petersburg Institute of Bioregulation and Gerontology (Khavinson group) as a short-peptide bioregulator targeting brain tissue. Hypothesized mechanism: tissue-specific gene-expression modulation via DNA binding. Russian preclinical data on neuroprotection and oxidative-stress reduction.

EVIDENCE GRADES

Neuroprotection (rodent oxidative stress)C

Khavinson group preclinical evidence describes reduced oxidative damage and improved neuronal survival in stress models.

DNA-binding / gene-expression modulation (in vitro)C

Khavinson hypothesis: short peptides bind specific DNA promoter sequences to modulate tissue-specific gene expression. Limited replication outside Russian Academy of Sciences.

Human cognitive outcomesD

Limited Western-indexed RCT evidence as of 2026.

MECHANISM CATEGORIES

RESEARCH CONDITIONS

SAFETY

Side effects

  • Generally well-tolerated in preclinical and small Russian clinical studies
  • Limited Western safety data

Known interactions

  • Largely unstudied

Contraindications

  • Pregnancy/lactation (unstudied)
  • Hypersensitivity

REGULATORY STATUS

FDA · Not FDA-approved. Research-use only in the United States.

WADA · Not currently listed on the WADA Prohibited List (2026).

STORAGE

Lyophilized · 2-8 °C, 24 months

Reconstituted · 2-8 °C, 28 days

PEER-REVIEWED EVIDENCE

  • Khavinson VK, Kuznik BI, Tarnovskaya SI. Short peptides and gene regulation in aging. Bull Exp Biol Med 2012. link →
  • Khavinson VK et al.. Neuroprotective effects of Khavinson's short peptides in stress models. Bull Exp Biol Med 2014. link →

FAQ · 8 QUESTIONS

What is Pinealon?

Pinealon is a synthetic tripeptide (Glu-Asp-Arg) developed at the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson's group. It is part of the Khavinson short-peptide bioregulator class targeting brain tissue.

Pinealon vs Epitalon · what's the difference?

Both are Khavinson short-peptide bioregulators. Epitalon (Ala-Glu-Asp-Gly) is a tetrapeptide derived from pineal-gland extracts and is studied for telomerase activation, pineal regulation, and longevity. Pinealon (Glu-Asp-Arg) is a tripeptide targeting brain tissue specifically, studied for neuroprotection and cognitive aging. Different sequences, different tissue targets within the same theoretical framework.

How does Pinealon work?

The Khavinson hypothesis proposes that short peptide bioregulators bind specific DNA promoter sequences and modulate tissue-specific gene expression. Pinealon is hypothesized to bind brain-tissue-specific promoters. The mechanism remains debated outside the Russian Academy of Sciences with limited Western replication.

Is Pinealon FDA-approved?

No. Research-use only in the United States.

Is Pinealon WADA-prohibited?

Pinealon is not currently listed on the WADA Prohibited List as of 2026.

What's the half-life of Pinealon?

Short plasma half-life (minutes). CNS retention is reportedly longer. Russian clinical protocols use intranasal administration to enhance brain delivery.

What's the research dose?

Russian preclinical and clinical literature describes 50-200 mcg per administration. No standardized human dose. This wiki does not recommend any human dose.

Is there Western peer-reviewed evidence?

Limited. The Khavinson group publishes primarily in Russian-language journals; a subset is indexed in Western journals through Bull Exp Biol Med and similar outlets. Independent Western replication is sparse.

SIGNATURE MOVES

Bioregulator PulsePOW 40

Tissue-specific gene-expression hypothesis.

Neuro ShieldPOW 70

Khavinson preclinical neuroprotection data.

SOURCED FROM PEPPU LABS

Reference compounds documented on this page are available as research-grade material at Peppu Studio · ≥99% purity · per-batch Certificate of Analysis. For laboratory research use only. No human dose is recommended by this wiki.

SOURCE AT PEPPU LABS ▶WIKI ENTRY ▶

▶ LAST UPDATED · 2026-05-25

© 2026 Peppu Studio LLC · For Laboratory Research Use Only